BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16386391)

  • 1. Pore size distributions of biodegradable polymer microparticles in aqueous environments measured by NMR cryoporometry.
    Petrov O; Furó I; Schuleit M; Domanig R; Plunkett M; Daicic J
    Int J Pharm; 2006 Feb; 309(1-2):157-62. PubMed ID: 16386391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of uniform biodegradable microparticles using laser ablation.
    Xie B
    Int J Pharm; 2006 Nov; 325(1-2):194-6. PubMed ID: 16901662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.
    Fischer S; Foerg C; Ellenberger S; Merkle HP; Gander B
    J Control Release; 2006 Mar; 111(1-2):135-44. PubMed ID: 16377017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas foamed open porous biodegradable polymeric microspheres.
    Kim TK; Yoon JJ; Lee DS; Park TG
    Biomaterials; 2006 Jan; 27(2):152-9. PubMed ID: 16023197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
    Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
    Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atmospheric plasma treatment of porous polymer constructs for tissue engineering applications.
    Safinia L; Wilson K; Mantalaris A; Bismarck A
    Macromol Biosci; 2007 Mar; 7(3):315-27. PubMed ID: 17366509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR cryoporometry characterisation studies of the relation between drug release profile and pore structural evolution of polymeric nanoparticles.
    Gopinathan N; Yang B; Lowe JP; Edler KJ; Rigby SP
    Int J Pharm; 2014 Jul; 469(1):146-58. PubMed ID: 24726633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The degradation of the three layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane in vitro.
    Liao S; Watari F; Zhu Y; Uo M; Akasaka T; Wang W; Xu G; Cui F
    Dent Mater; 2007 Sep; 23(9):1120-8. PubMed ID: 17095082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
    Haddadi A; Aboofazeli R; Erfan M; Farboud ES
    J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.